Donia Cherifi

Donia Cherifi serves as Vice President and Global Head of the Immunology Franchise at Galderma since March 2020, with prior roles including Head of Therapeutic Dermatology for Southern Europe and Nemolizumab Global Commercial Lead. Previously, Donia Cherifi held various positions at Celgene from September 2014 to February 2020, including Global Marketing Associate Director for Multiple Sclerosis and Senior Regional Product Manager for Rheumatology, where responsibilities encompassed brand strategy and launch readiness across multiple regions. Prior experience includes a tenure at MSD France from April 2007 to September 2014, where Donia Cherifi led key projects and contributed to marketing strategies for significant immunology products. Donia Cherifi holds a Specialized Master's degree in Engineering & Marketing of Biotechnology from Ionis School of Technology & Management and a Master's degree in Biochemistry & Molecular Biology from Université des Sciences Nancy I.